|

Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids

RECRUITINGSponsored by InSightec
Actively Recruiting
SponsorInSightec
Started2016-02-16
Est. completion2026-12-31
Eligibility
Age18 Years – 50 Years
SexFEMALE
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →

NCT05386615

Summary

The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.

Eligibility

Age: 18 Years – 50 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria: - - Eligibility is as per the symptomatic fibroids device indication. - All registry-consented patients following the treatment of their fibroid(s) with the Exablate system. Exclusion Criteria: -

Conditions2

CancerUterine Fibroid

Locations3 sites

California

2 sites
UCLA
Los Angeles, California, 90095
Polly Kay, RN, CCRP310-794-0376pkay@mednet.ucla.edu
Stanford University
Stanford, California, 94305
Caroline Huang650-725-6409chuang99@stanford.edu

Minnesota

1 site
Mayo Clinic
Rochester, Minnesota, 55905
Brittany Yaklich507-538-7765FOCUSEDULTRASOUND@mayo.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.